Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains? In total, 1,018 patients completed induction treatment and were randomly assigned to rituximab maintenance (n = 505) or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results